What happens when agglutinins encounter their specific agglutinogen in a blood transfusion with incompatible blood types?

When agglutinins (antibodies) in a recipient's plasma encounter their corresponding agglutinogens (antigens) on the surface of transfused donor red blood cells, the result is agglutination — the clumping or clustering of red blood cells into large masses. Agglutinins are Y-shaped antibody molecules capable of binding to antigens on two different red blood cells simultaneously, forming cross-linked networks that cause cells to clump together. This is the hallmark of an ABO incompatibility reaction. Following agglutination, the clumped cells activate the complement cascade, ultimately leading to hemolysis — destruction of the red blood cells — which is the catastrophic event in an acute hemolytic transfusion reaction. Breakdown of hemoglobin is a downstream consequence of hemolysis, not the direct initial result of agglutinin-agglutinogen binding, making it a secondary rather than primary response. The claim of no immune response is incorrect because the antigen-antibody interaction is precisely an immune response. Increasing oxygen transport is also incorrect; in fact, transfusion incompatibility severely impairs oxygen delivery by destroying red cells. Understanding this mechanism underscores why strict blood typing and crossmatching before any transfusion is a critical safety measure in clinical practice.